SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023)

被引：2

作者：

Perez-Fidalgo, Jose Alejandro ^{[1
]}

Galvez-Montosa, Fernando ^{[2
]}

Guerra, Eva Maria ^{[3
]}

Madariaga, Ainhoa ^{[4
]}

Manzano, Aranzazu ^{[5
]}

Martin-Lorente, Cristina ^{[6
]}

Rubio-Perez, Maria Jesus ^{[7
]}

Alarcon, Jesus ^{[8
]}

Barretina-Ginesta, Maria Pilar ^{[9
]}

Gaba, Lydia ^{[10
]}

机构：

[1] Univ Valencia, Hosp Clin Univ, Biomed Res Inst INCL, Valencia, Spain

[2] Hosp Univ Jaen, Jaen, Spain

[3] Hosp Univ Ramon y Cajal, Madrid, Spain

[4] 12 Octubre Univ Hosp, Dept Med Oncol, Madrid, Spain

[5] Hosp Clin San Carlos, Madrid, Spain

[6] Hosp Santa Creu & Sant Pau, Radiol, Barcelona, Spain

[7] Univ Cordoba UCO, Hosp Univ Reina Sofia, Cordoba, Spain

[8] Hosp Univ Son Espases, Mallorca, Spain

[9] Univ Girona, Inst Invest Biomed Girona IDIBGI, Med Sci Dept, Inst Catala Oncol,Med Oncol Dept,Precis Oncol Grp, Girona, Spain

[10] Univ Barcelona, Hosp Clin, Translat Genom & Targeted Therapies Solid Tumors, Med Oncol Dept,IDIBAPS,Dept Med, Barcelona, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期

关键词：

Ovarian cancer; Guideline; Diagnosis; Treatment; PEGYLATED LIPOSOMAL DOXORUBICIN; OPEN-LABEL; MAINTENANCE THERAPY; DOUBLE-BLIND; SECONDARY CYTOREDUCTION; PLUS BEVACIZUMAB; RECURRENT; CHEMOTHERAPY; MULTICENTER; OLAPARIB;

D O I：

10.1007/s12094-024-03531-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In recent years, the incorporation of new strategies to the therapeutic armamentarium has completely changed the outcomes of epithelial ovarian cancer (EOC). The identification of new predictive and prognostic biomarkers has also enabled the selection of those patients more likely to respond to targeted agents. Nevertheless, EOC is still a highly lethal disease and resistance to many of these new agents is common. The objective of this guideline is to summarize the most relevant strategies to manage EOC, to help the clinician throughout the challenging diagnostic and therapeutic processes and to provide evidence-based recommendations.

引用

页码：2758 / 2770

页数：13

共 50 条

[41] SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
Mendez-Vidal, Maria Jose
Quintela, Martin Lazaro
Lainez-Milagro, Nuria
Perez-Valderrama, Begona
Rodriguez, Cristina Suarez
Arija, Jose Angel Arranz
Fernandez, Ignacio Pelaez
Diaz, Enrique Gallardo
Sorrosal, Julio Lambea
Gonzalez-del-Alba, Aranzazu
CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (09): : 2732 - 2748
[42] SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)
Martin-Richard, M.
Diaz Beveridge, R.
Arrazubi, V.
Alsina, M.
Galan Guzman, M.
Custodio, A. B.
Gomez, C.
Munoz, F. L.
Pazo, R.
Rivera, F.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12): : 1179 - 1186
[43] SEOM—GECOD clinical guideline for unknown primary cancer (2021)
Ferrán Losa
Isaura Fernández
Olatz Etxaniz
Alejandra Giménez
Paula Gomila
Lara Iglesias
Federico Longo
Esteban Nogales
Antonio Sánchez
Gemma Soler
Clinical and Translational Oncology, 2022, 24 : 681 - 692
[44] Systemic therapy for recurrent epithelial ovarian cancer: a clinical practice guideline
Francis, J.
Coakley, N.
Elit, L.
Mackay, H.
CURRENT ONCOLOGY, 2017, 24 (06) : E540 - E546
[45] SEOM clinical guidelines in Hereditary Breast and ovarian cancer
G. Llort
I. Chirivella
R. Morales
R. Serrano
A. Beatriz Sanchez
A. Teulé
E. Lastra
J. Brunet
J. Balmaña
B. Graña
Clinical and Translational Oncology, 2015, 17 : 956 - 961
[46] SEOM clinical guidelines in Hereditary Breast and ovarian cancer
Llort, G.
Chirivella, I.
Morales, R.
Serrano, R.
Beatriz Sanchez, A.
Teule, A.
Lastra, E.
Brunet, J.
Balmana, J.
Grana, B.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12): : 956 - 961
[47] SEOM clinical guideline emesis (2021)
Majem, Margarita
de las Penas, Ramon
Antonio Virizuela, Juan
Cabezon-Gutierrez, Luis
Cruz, Patricia
Lopez-Castro, Rafael
Mendez, Miriam
Mondejar, Rebeca
del Mar Munoz, Maria
Escobar, Yolanda
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (04): : 712 - 723
[48] Clinical guideline SEOM: hepatocellular carcinoma
J. Sastre
R. Díaz-Beveridge
J. García-Foncillas
R. Guardeño
C. López
R. Pazo
N. Rodriguez-Salas
M. Salgado
A. Salud
J. Feliu
Clinical and Translational Oncology, 2015, 17 : 988 - 995
[49] Clinical guideline SEOM: hepatocellular carcinoma
Sastre, J.
Diaz-Beveridge, R.
Garcia-Foncillas, J.
Guardeno, R.
Lopez, C.
Pazo, R.
Rodriguez-Salas, N.
Salgado, M.
Salud, A.
Feliu, J.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12): : 988 - 995
[50] SEOM 2023 clinical guidelines
Montes, Ana Fernandez
Rodriguez, Cesar
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11): : 2755 - 2757

← 1 2 3 4 5 →